Analysis of the D4 Dopamine Receptor Gene Variant in an Italian Schizophrenia Kindred

Archives of General Psychiatry

Volumn 51, Issue 4, 1994, Pages 288-293

  Macciardi, Fabio ^a   Petronis, Arturas ^b   van Tol, Hubert H M ^b   Marino, Cecilia ^a   Cavallini, M Cristina ^a   Smeraldi, Enrico ^a   Kennedy, James L ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; TYROSINE 3 MONOOXYGENASE; CLOZAPINE; DOPAMINE;

ARTICLE; ETHNOLOGY; FAMILY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HUMAN; ITALY; METABOLISM; POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SOUTHERN BLOTTING; DRUG RECEPTOR BINDING; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; MAJOR CLINICAL STUDY; PATHOGENESIS; RECEPTOR AFFINITY;

BLOTTING, SOUTHERN; FAMILY; HUMAN; ITALY; LINKAGE (GENETICS); LOD SCORE; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); RECEPTORS, DOPAMINE; SCHIZOPHRENIA; TYROSINE 3-MONOOXYGENASE; VARIATION (GENETICS);

EID: 0028182870     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1994.03950040032004     Document Type: Article

References (47)

1. Gottesman II, Shields J. Schizophrenia: The Epigenetic Puzzle. New York, NY: Cambridge University Press; 1982.
2. Kendler K. The genetics of schizophrenia and related disorders: a review. In: Dunner D, Gershon E, Barret J, eds. Relative at Risk for Mental Disorders. New York, NY: Raven Press; 1988: 247–266.
3. Kennedy JL, Giuffra L. Recent developments in genetic linkage studies of schizophrenia. In: Tamminga CA, Schultz SC, eds. Advances in Neuropsychiatry and Psychopharmacology. New York, NY: Raven Press; 1991: 21–31.
4. Smeraldi E, Macciardi F, Gasperini M, Orsini A, Bellodi L, Fabio G, Morabito A. Genetic modelling in schizophrenia according to HLA typing. Clin Genet. 1986;30: 157–166.
5. Tsuang MT, Lyons MJ, Faraone SV. Clinical phenotypes: problem in diagnosis. In: Mendlewicz J, Hippius H, eds. Genetic Research in Psychiatry. Berlin, Germany: Springer-Verlag; 1992: 173–192.
6. Sherrington R, Brynjolfsson J, Peturson H, Potter M, Dudleston K, Barraclough B, Wasmuth J, Dobbs M, Gurling H. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature. 1988;336: 164–167.
7. Kennedy JL, Giuffra L, Moises H, Cavalli-Sforza L, Pakstis A, Kidd J, Castiglione C, Sjogren B, Wetterberg L, Kidd KK. Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature. 1988;336: 167–170.
8. Risch N. Genetic linkage and complex disease with special reference to psychiatric disorders. Genet Epidemiol. 1990;7: 3–16.
9. Mankoo B, Sherrington R, Brynjolfsson J, Kalsi G, Petursson H, Sigmundsson T, Read T, Murphy P, Curtis D, Melmer G, Gurling H. New microsatellite polymorphisms provide a highly polymorphic map of chromosome 5 bands q11.2-q13.3 for linkage analysis of Icelandic and English families affected by schizophrenia. Psychiatr Genet. 1991;2:17.
10. Macciardi F, Kennedy JL, Ruocco L, Giuffra L, Carrera P, Marino C, Rinaldi V, Smeraldi E, Ferrari M. A genetic linkage study of schizophrenia to chromosome 5 markers in a northern Italian population. Biol Psychiatry. 1992;31: 720–728.
11. Schellenberg GD, Anderson L, O'Dahl S, Wijsman EM, Sadovnick AD, Ball MJ, Larson EB, Kukull WA, Martin GM, Roses AD, Bird TA. APP717, APP693, and PRIP gene mutations are rare in Alzheimer disease. Am J Hum Genet. 1991;49: 511–517.
12. Milner RJ, Sutcliff JG. Gene expression in rat brain. Nucleic Acid Res. 1983;11: 5497–5520.
13. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1987;1: 133–152.
14. Losonczy MF, Davidson M, Davis KL. The dopamine hypothesis of schizophrenia. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press;1987: 715–726.
15. Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science. 1975;188: 1217–1219.
16. Lee T, Seeman P, Tourtellotte WW, Farley IJ, Hornikiewicz O. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brain. Nature. 1978;274: 897–900.
17. Seeman P, Ulpian C, Bergeron C, Riederer P, Jellinger K, Gabriel E, Reynolds GP, Tourtellotte WW. Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science. 1984;225: 728–730.
18. Kornhuber J, Riederer P, Reynolds GP, Beckmann H, Jellinger K, Gabriel E. 3H-Spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J Neural Transm. 1989;75: 1–10.
19. Farde L, Wiesel FA, Stone-Elander S, Sedvall G. No D2 receptor increase in PET study of schizophrenia. Arch Gen Psychiatry. 1987;44: 671–672.
20. Moises HW, Gelernter J, Giuffra LA, Zarcone V, Wetterberg L, Civelli O, Kidd KK, Cavalli-Sforza LL, Grandy DK, Kennedy JL, Vinogradov S, Mauer J, Litt M, Sjogren B. No linkage between D2 dopamine receptor gene region and schizophrenia. Arch Gen Psychiatry. 1991;48: 643–647.
21. Kane J, Honigfeld G, Singer J, Meltzer HY. Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry. 1988;45: 789–796.
22. Meltzer HY. Clozapine: clinical advantages and biologic mechanisms. In: Schultz SC, Tamminga CA, eds. Schizophrenia: Scientific Progress. New York, NY: Oxford University Press; 1989: 302–309.
23. Van Tol HHM, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1991;350: 610–614.
24. Kennedy JL, Sidenberg DG, Van Tol HHM, Kidd KK. A Hincll RFLP in the human D4 dopamine receptor locus (DRD4). Nucleic Acids Res. 1991;19:5805.
25. Gelernter J, Kennedy JL, Van Tol HHM, Civelli O, Kidd KK. The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics. 1992;13: 208–210.
26. Leboyer M, Malafosse A, Boularand S, Campion D, Gheysen F, Samolyk D, Henriksson B, Denise E, Des Lauriers A, Lepine JP, Zarifian E, Clerget-Darpoux F, Mallet J. Tyrosine hydroxylase polymorphisms associated with manic-depressive illness. Lancet. 1990;335:1219.
27. Van Tol HHM, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, Kennedy JL, Seeman P, Niznik HB, Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature. 1992;358: 149–152.
28. Petronis A, Van Tol HHM, Livak KJ, Lichter J, Macciardi FM, Sidenberg DG, Kennedy JL. Genetic analysis of variable repeat sequence in DRD4 gene exon. Am J Hum Genet. 1992;51:A198. Abstract.
29. Kennedy JL, Van Tol HHM, Petronis A, Sidenberg DG, Honer WG, Macciardi FM, Bassett AS. Genetic linkage studies of DRD4 variants in schizophrenia. Am J Hum Genet. 1992;51(suppl):A365. Abstract.
30. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS). New York, NY: New York State Psychiatric Institute; 1978.
31. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98: 503–517.
32. Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK, Livak KJ. A hypervariable segment in the human dopamine receptor (DRD4) gene. Hum Mol Genet. 1993;2: 767–773.
33. Edwards A, Civitello A, Hammond HA, Caskey CT. DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet. 1991;49: 746–756.
34. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics. 1992;12: 241–253.
35. Clerget-Darpoux F, Bana:ti-Pellie' C, Hochez J. Effects of misspecifying genetic parameters in lod score analysis. Biometrics. 1986;42: 393–399.
36. Clerget-Darpoux F, Babron MC, Bana:ti-Pellie' C. Assessing the effect of multiple linkage tests in complex diseases. Genet Epidemiol. 1990;7: 245–253.
37. Vogler GP, Gottesman II, McGue MK, Rao DC. Mixed model segregation analysis of schizophrenia in the Lindelius Swedish pedigrees. Behav Genet. 1990;20: 461–472.
38. Asherson P, Parfitt E, Sargeant M, Tidmarsh S, Buckland P, Taylor C, Clements A, Gill M, McGuffin P, Owen M. No evidence for a pseudoautosomal locus for schizophrenia: linkage analysis of multiple affected families. Br J Psychiatry. 1991;161: 63–68.
39. Lathrop M, Lalouel JM, Julier C, Ott J. Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet. 1985;37: 482–498.
40. Risch N. Linkage strategies for genetically complex traits, I: multilocus model. Am J Hum Genet. 1991;46: 219–221.
41. Lathrop GM, Ott J. Analysis of complex diseases under oligogenic models and intrafamilial heterogeneity by the LINKAGE programs. Am J Hum Genet. 1990;47:A188. Abstract.
42. Macciardi F, Cavallini MC. A 2-locus model for Alzheimer's disease? Read before the Eighth Genetic Analysis Workshop; November 9, 1992; San Francisco, Calif.
43. Merette C, Lehner T, Leal S, Ott J. Two approaches toward linkage heterogeneity of FAD: age of onset and the two locus model of epistasis. Read before the Eighth Genetic Analysis Workshop; November 9, 1992; San Francisco, Calif.
44. Vieland VJ, Hodge SE, Greenberg DA. Adequacy of single-locus approximations for linkage analyses of oligogenic traits. Genet Epidemiol. 1992;9: 45–60.
45. Risch N, Giuffra L. Model misspecifications and multipoint linkage analysis. Hum Hered. 1992;42: 77–92.
46. Lawrence JB. A fluorescence in situ hybridization approach for gene mapping and the study of nuclear organization. In: Davies KE, Tilghman SM, eds. Genetic and Physical Mapping. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1990: 1–38.
47. Smeraldi E, Macciardi F. The ‘candidate gene’ approach to the genetics of schizophrenia and other psychoses. In: Racagni G, Brunell N, Fukuda T, eds. Biological Psychiatry: Proceedings of the Fifth World Congress of Biological Psychiatry. Amsterdam, the Netherlands: Elsevier Science Publishers; 1991;2: 465–468.